Amgen, Inc. vs SiTime Corporation — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while SiTime Corporation trades at $683 (market cap $20.05B). The key difference: Amgen, Inc. is far larger — about 11.2× SiTime Corporation's market cap, and Amgen, Inc. pays a 2.43% dividend while SiTime Corporation pays none. Which is the better fit depends on your goals.
| AMGN | SITM | |
|---|---|---|
Market Cap | $224.14B | $20.05B |
Sector | Health | Technology |
52-Week High | $417.20 | $901.60 |
52-Week Low | $271.18 | $212.77 |
Enterprise Value | $267.45B | $19.45B |
Dividend Yield | 2.43% | — |
Trailing returns across standard periods
Latest headlines on both assets
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →